All terms in CMPO
| Label | Id | Description |
|---|---|---|
| 2-D extent | PATO_0001709 | [A size quality inhering in an bearer by virtue of the bearer's extension in two dimensions.] |
| increased duration of mitotic prophase phenotype | CMPO_0000328 | [A phenotype observation where the duration of the mitotic prophase of the cell cycle is increased] |
| surrounding | PATO_0001772 | [A spatial quality inhering in a bearer by virtue of the bearer's being extended on all sides of another entity simultaneously.] |
| round focal adhesion | CMPO_0000337 | [A phenotype observation where the shape of the focal adhesion has every part of the surface or the circumference equidistant from the center.] |
| macromolecular complex | GO_0032991 | [A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which the constituent parts function together.] |
| bright nuclear body phenotype | CMPO_0000335 | [A phenotype obervation where the nuclear body's color brightness is relatively high.] |
| nuclear body phenotype | CMPO_0000125 | [A phenotype observation at the level of the nuclear body, an extra-nucleolar nuclear domains usually visualized by confocal microscopy and fluorescent antibodies to specific proteins.] |
| cytoplasmic sequestering of NF-kappaB phenotype | CMPO_0000332 | [A phenotype observation where the frequency of a process that stops, prevents, or reduces the frequency, rate or extent of the activity of the transcription factor NF-kappaB is increased.] |
| regulation of signal transduction phenotype | CMPO_0000040 | [A phenotype observation of a process that modulates the frequency, rate or extent of signal transduction.] |
| abnormal release of cytoplasmic sequestered NF-kappaB phenotype | CMPO_0000333 | [A phenotype observation where the release of NF-kappaB from specific molecules in the cytoplasm to which it was bound, thereby allowing its translocation into the nucleus, is abnormal.] |
| decreased frequency of negative regulation of NF-kappaB transcription factor activity phenotype | CMPO_0000330 | [A phenotype observation where the frequency of a process that stops, prevents, or reduces the frequency, rate or extent of the activity of the transcription factor NF-kappaB is decreased.] |
| regulation of metabolic process phenotype | CMPO_0000039 | [A phenotype observation where a process modulates the frequency, rate or extent of the chemical reactions and pathways within a cell or an organism.] |
| increased frequency of negative regulation of NF-kappaB transcription factor activity phenotype | CMPO_0000331 | [A phenotype observation where the frequency of a process that stops, prevents, or reduces the frequency, rate or extent of the activity of the transcription factor NF-kappaB is increased.] |
| protein localization to bud neck | GO_0097271 | [A process in which a protein is transported to, or maintained at, a location within a cellular bud neck.] |
| death | GO_0016265 | [A permanent cessation of all vital functions: the end of life; can be applied to a whole organism or to a part of an organism.] |
| cytoplasmic membrane-bounded vesicle | GO_0016023 | [A membrane-bounded vesicle found in the cytoplasm of the cell.] |
| cytoplasmic vesicle | GO_0031410 | [A vesicle formed of membrane or protein, found in the cytoplasm of a cell.] |
| maintenance of location | GO_0051235 | [Any process in which a cell, substance or cellular entity, such as a protein complex or organelle, is maintained in a location and prevented from moving elsewhere.] |
| regulation of biological quality | GO_0065008 | [Any process that modulates a qualitative or quantitative trait of a biological quality. A biological quality is a measurable attribute of an organism or part of an organism, such as size, mass, shape, color, etc.] |
| establishment of localization | GO_0051234 | [The directed movement of a cell, substance or cellular entity, such as a protein complex or organelle, to a specific location.] |